MigShield
MigShield, licence 80082989: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- QH Holdings (Oregon), dba Quantum Inc., and Quantum Health
- NPN or DIN-HM
- 80082989
- Status
- Active licence
- Licence date
- 8 February 2018
- Revision date
- Not provided
- Form
- Comprimé
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 200.0 milligramme | Not calculated |
| Magnésium Source : Oxyde de magnésium | 200.0 milligramme | Not calculated |
| Magnésium Source : Citrate de magnésium | 200.0 milligramme | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Rhodobacter sphaeroides - Cellule entière pour biosynthèse | 75.0 milligramme | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Acide stéarique, Dioxyde de silicium, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Comprimé | 2.0 Tous les jours |
Uses authorised in Canada
Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic. Helps in the development and maintenance of bones and teeth.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking blood pressure medication. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner if migraine frequency increases, and associated nausea and vomiting persist or worsen. Hypersensitivity has been known to occur; in which case, discontinue use.
- Effets indésirables connus
Some people may experience diarrhoea.
Source
Official Health Canada record, licence 80082989
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.